Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29,545,622
-
Total 13F shares
-
6,515,002
-
Share change
-
+276,152
-
Total reported value
-
$15,567,000
-
Price per share
-
$2.39
-
Number of holders
-
43
-
Value change
-
+$1,002,011
-
Number of buys
-
21
-
Number of sells
-
20
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q2 2017
As of 30 Jun 2017,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,515,002 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, InterWest Venture Management Co, BlackRock Inc., Connor, Clark & Lunn Investment Management Ltd., FMR LLC, WASATCH ADVISORS INC, OxFORD Asset Management LLP, Ancora Advisors, LLC, and ClariVest Asset Management LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.